Formulation Development Solutions
-
Gain Human-Relevant Insights With Patient-Derived Assay-Ready Organoids
3/31/2025
3D organoids offer enhanced physiological relevance and are ready to use from cryopreserved vials. Discover how they can streamline your research with high-quality and comprehensive support.
-
Developing Palatable, Age Appropriate Drug Products
10/15/2025
Our expertise and capabilities enable us to meet the complex technical challenges of pediatric products and provide you with a unique integrated development solution.
-
Drug-Drug Interaction (DDI) Studies
10/16/2023
Learn how an innovative development platform with the unique ability to fully integrate DDI studies accelerate timelines and improve the likelihood of downstream success.
-
Chip-R1™ Basic Research Kit
10/15/2024
Discover how you can improve precision in ADME and toxicology applications with a low-drug absorption profile.
-
High Potency Handling Capabilities And Support
10/15/2025
Highly potent APIs require stringent containment and precise manufacturing controls. Specialized facilities offer end-to-end development solutions and robust cross-contamination protections.
-
An Organ-Chip Platform That Generates Human-Relevant Data At Scale
12/18/2025
Generate human-relevant data with an Organ-Chip system that combines automation, imaging, and cost efficiency for faster, more confident insights for drug development and complex biological studies.
-
Resin Offering High Productivity And Robust Processes
5/3/2023
MabSelect™ VL affinity resin uses a protein L ligand with strong affinity for the variable region of a human antibody’s kappa light chain. The resin offers high productivity and robust processes for affinity capture of bispecific antibodies and antibody fragments containing the kappa light chain and offers a good capture alternative for antibody variants that does not bind to protein A.
-
The Way Forward In Antibody Therapeutics Purification
8/11/2022
We have developed an innovative portfolio of affinity chromatography resins to support you in the downstream process of next-generation antibody therapeutics.
-
Increased Productivity Powered By An Automation Workstation
10/10/2025
Boost genomics productivity with a solution built for speed, precision, and high throughput with extended walkaway times and reliable performance that helps teams get more done.
-
Early Development: Accelerating Molecules Through To Proof-Of-Concept
3/3/2022
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.